Tamoxifen and toremifene concentrations in plasma are greatly decreased by rifampin (Q77743587)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9871429%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

title

Tamoxifen and toremifene concentrations in plasma are greatly decreased by rifampin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9871429%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference

1 reference

K T Kivistö

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9871429%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

K Villikka

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9871429%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

L Nyman

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9871429%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

M Anttila

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9871429%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

P J Neuvonen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9871429%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

publication date

1 December 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9871429%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacology & Therapeutics

8 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9871429%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

volume

64

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9871429%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9871429%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

page(s)

648-654

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9871429%20AND%20SRC:MED&resulttype=core&format=json

Tamoxifen. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic use.

8 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990055-8

Pharmacokinetics of toremifene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990055-8

Toremifene. A review of its pharmacological properties and clinical efficacy in the management of advanced breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990055-8

Identification of the cytochrome P450 IIIA family as the enzymes involved in the N-demethylation of tamoxifen in human liver microsomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990055-8

Involvement of cytochrome P450 3A enzyme family in the major metabolic pathways of toremifene in human liver microsomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990055-8

The role of human cytochrome P450 enzymes in the metabolism of anticancer agents: implications for drug interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990055-8

Bioavailability of cyclosporine with concomitant rifampin administration is markedly less than predicted by hepatic enzyme induction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990055-8

Rifampin drastically reduces plasma concentrations and effects of oral midazolam.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990055-8

Differential induction of prehepatic and hepatic metabolism of verapamil by rifampin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990055-8

Triazolam is ineffective in patients taking rifampin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990055-8

Pharmacokinetics of the novel antiestrogenic agent toremifene in subjects with altered liver and kidney function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990055-8

Time course of the changes in prednisolone pharmacokinetics after co-administration or discontinuation of rifampin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990055-8

Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990055-8

Concentrations and effects of oral midazolam are greatly reduced in patients treated with carbamazepine or phenytoin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990055-8

Tamoxifen metabolic patterns within a glioma patient population treated with high-dose tamoxifen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990055-8

10.1016/S0009-9236(98)90055-8

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9871429%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference